News and Events

Latest News

Mobidiag Secures Additional Funding from Business Finland for Development of Rapid Sepsis Diagnostics Test Directly from Blood

Published on 29 May 2018

Mobidiag announced today that it has initiated the development of a sepsis assay on the new Novodiag® system thanks to a €1.5 million loan from Business Finland.


Read More




Mobidiag Secures Additional €4 Million in Capital Increase with Springvest´s Public Financing Round

Published on 24 May 2018

Mobidiag  has successfully completed a 4 million euros funding supported by the Finnish investment service company Springvest Oy (former Kansalaisrahoitus) for its global business development, including its capacity to answer growing needs for the new Novodiag® solution.


Read More




NEW! Amplidiag® CarbaR+MCR, a multiplex qPCR test for detection of antibiotic resistant bacteria

Published on 19 Apr 2018

CE-IVD marking of Amplidiag® CarbaR+MCR, a molecular test allowing detection of the main carbapenemase-producing organisms and colistin resistance markers in one single test.


Read More




Upcoming Events

RICAI 2018
Dec. 17-18, 2018


JBP 2018
Dec. 7-8, 2018


UK NEQAS 2018
Nov. 30, 2018


HIS 2018
Nov. 26-28, 2018


FIS Conference 2018
Nov. 13-15, 2018




© Copyright Mobidiag Ltd. All Rights Reserved. Learn more about our Privacy policy.